Tao Wei
-
- Thyroid Cancer Diagnosis and Treatment 57
- Nephrology top 5%
- Parathyroid Disorders and Treatments 6
- Cancer Research top 10%
- MicroRNA in disease regulation 6
- Surgery top 10%
- Thyroid and Parathyroid Surgery 37
- Head and Neck Anomalies 16
-
- Biomarkers in Disease Mechanisms 6
-
- Radiomics and Machine Learning in Medical Imaging 5
-
- Extracellular vesicles in disease 5
- Journals
- Journal of the American Chemical Society (1 paper)Journal of Biological Chemistry (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Tao Wei
83 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 81
- Endocrinology, Diabetes and Metabolism 655
- Nephrology 90
- Cancer Research 164
- Surgery 453
- Endocrine and Autonomic Systems 43
Countries citing papers authored by Tao Wei
This map shows the geographic impact of Tao Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Wei more than expected).
Fields of papers citing papers by Tao Wei
This network shows the impact of papers produced by Tao Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Wei. The network helps show where Tao Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tao Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 5 | |
| 7 | 2023 | 14 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 12 | |
| 10 | 2022 | 3 | |
| 11 | 2021 | 75 | |
| 12 | 2021 | 8 | |
| 13 | 2020 | 10 | |
| 14 | 2020 | 29 | |
| 15 | 2020 | 15 | |
| 16 | 2019 | 27 | |
| 17 | 2018 | 24 | |
| 18 | 2018 | 20 | |
| 19 | 2017 | 25 | |
| 20 | 2003 | 43 |
About Tao Wei
Tao Wei is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Nephrology, having authored 94 papers that have together received 1.2k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (57 papers), Thyroid and Parathyroid Surgery (37 papers), Head and Neck Anomalies (16 papers), Biomarkers in Disease Mechanisms (6 papers), Parathyroid Disorders and Treatments (6 papers), MicroRNA in disease regulation (6 papers), Radiomics and Machine Learning in Medical Imaging (5 papers) and Extracellular vesicles in disease (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (655 citations), Nephrology (90 citations) and Cancer Research (164 citations). Tao Wei has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jingqiang Zhu, Zhihui Li, Rixiang Gong, Jianyong Lei, Jingqiang Zhu, Wenjie Chen, Xiaofei Wang, Genpeng Li, Zhihui Li and Xiuhe Zou. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.